Stability of selected serum proteins after long-term storage in the Janus Serum Bank

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 5, 2009, Pages 596-603

  Gislefoss, Randi E ^a,b,c   Grimsrud, Tom K ^a   Mørkrid, Lars ^b  

^a Cancer Registry of Norway   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Biobank; Biomarker; Blood based epidemiology; Serum proteins; Stability; Temperature

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; CREATINE KINASE; CYSTATIN C; FERRITIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; SEX HORMONE BINDING GLOBULIN; TRANSFERRIN;

ADULT; ARTICLE; CENTRAL TENDENCY BIAS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SERUM; STORAGE;

ADULT; BLOOD BANKS; BLOOD PROTEINS; HUMANS; MALE; MIDDLE AGED; PROTEIN STABILITY; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS;

EID: 67649232884     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.121     Document Type: Article

References (51)

1. Berg JP, Henninge J, Lund T. Determination of new biomarkers in the plasma proteome. Nor J Epidemiol 2006;16:35-40.
2. Carpenter JF, Manning MC, Randolph TW. Long-term storage of proteins. Curr Protoc Protein Sci 2002 Supplement 27; Chapter 4:Unit 4.6.1-4.6.6.
3. Landi MT, Caporaso N. Sample collection, processing and storage. IARC Sci Publ 1997;142:223-36.
4. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. The JANUS serum bank. Sci Total Environ 1993;139-140:527-35.
5. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. Experiences of the Janus Serum Bank in Norway. Environ Health Perspect 1995;103(Suppl 3): 85-8.
6. Zhou Q, Li S, Li X, Wang W, Wang Z. Detection of outliers and establishment of targets in external quality assessment programs. Clin Chim Acta 2006;372:94-7.
7. Kenny D, Solberg HE. RefVal for Windows - migrating to the Windows environment with the help of Visual Basic. Clin Chim Acta 1993;222:19-21.
8. Ricós C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500.
9. Westgard. Biological variation database, and quality specifications for imprecision, bias and total error. The 2006 update. http://www.westgard.com/ guest32.htm. 2009.
10. Sonntag O. Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem 1986;24: 127-39.
11. Urdal P, Bolann B, Marstein S, Rustad P, Steensland H, Asberg A. [Updated reference intervals for clinical chemical components]. Tidsskr Nor Laegeforen 2004; 124:1515-7.
12. Creighton TE. Protein folding. Biochem J 1990;270:1-16.
13. Voet D, Voet J. Post-translational modification. In: Nedah Rose, editor. Biochemistry. New York, Chichester, Brisbane, Toronto, Singapore: John Wiley & Sons, Inc, 1995:1009.
14. Clark S, Youngman LD, Palmer A, Parish S, Peto R, Collins R. Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies. Int J Epidemiol 2003;32:125-30.
15. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989;35:2313-6.
16. Holl K, Lundin E, Kaasila M, Grankvist K, Afanasyeva Y, Hallmans G, et al. Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort. Acta Oncol 2008;47:406-12.
17. Kristal AR, King IB, Albanes D, Pollak MN, Stanzyk FZ, Santella RM, et al. Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability. Cancer Epidemiol Biomarkers Prev 2005;14:727-30.
18. Laessig RH, Indriksons AA, Hassemer DJ, Paskey TA, Schwartz TH. Changes in serum chemical values as a result of prolonged contact with the clot. Am J Clin Pathol 1976;66:598-604.
19. Ono T, Kitaguchi K, Takehara M, Shiiba M, Hayami K. Serum-constituents analyses: effect of duration and temperature of storage of clotted blood. Clin Chem 1981;27:35-8.
20. Boyanton BL Jr, Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002;48:2242-7.
21. Zhang DJ, Elswick RK, Miller WG, Bailey JL. Effect of serum-clot contact time on clinical chemistry laboratory results. Clin Chem 1998;44:1325-33.
22. Kenny D, Solberg HE. RefVal for Windows - migrating to the Windows environment with the help of Visual Basic. Clin Chim Acta 1993;222:19-21.
23. Solberg HE. Establishment and use of reference values. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. St. Louis, Missouri: Elsevier Saunders, 2006:437.
24. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev 2004;25:105-20.
25. Hurley JH, Dean AM, Thorsness PE, Koshland DE Jr, Stroud RM. Regulation of isocitrate dehydrogenase by phosphorylation involves no long-range conformational change in the free enzyme. J Biol Chem 1990;265: 3599-602.
26. Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 2003;14:327-34.
27. Petridou ET, Chavelas C, Dikalioti SK, Dessypris N, Terzidis A, Nikoulis DI, et al. Breast cancer risk in relation to most prevalent IgE specific antibodies: a case control study in Greece. Anticancer Res 2007;27:1709-13.
28. Vesterinen E, Pukkala E, Timonen T, Aromaa A. Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol 1993;22:976-82.
29. Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer 2006;119:695-701.
30. Ovary Z, Itaya T, Santomauro J, Richmond G. On the stability of IgE antibodies. J Immunol Methods 1978; 24:193-4.
31. Henderson CE, Ownby D, Klebanoff M, Levine RJ. Stability of immunoglobulin E (IgE) in stored obstetric sera. J Immunol Methods 1998;213:99-101.
32. Zetterstrom O, Johansson SG. IgE concentrations measured by PRIST in serum of healthy adults and in patients with respiratory allergy. A diagnostic approach. Allergy 1981;36:537-47.
33. Gislefoss RE, Grimsrud TK, Morkrid L. Long-term stability of serum components in the Janus Serum Bank. Scand J Clin Lab Invest 2008;68:402-9.
34. Theil EC, Sayers DE, Brown MA. Similarity of the structure of ferritin and iron. Dextran (imferon) determined by extended X-ray absorption fine structure analysis. J Biol Chem 1979;254:8132-4.
35. Høstmark AT, Glattre E, Jellum E. Effect of long-term storage on the concentration of albumin and free fatty acids in human sera. Scand J Clin Lab Invest 2001;61: 443-7.
36. Stroud LR, Solomon C, Shenassa E, Papandonatos G, Niaura R, Lipsitt LP, et al. Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years. Psychoneuroendocrinology 2007;32:140-50.
37. Giovannucci E, Rimm EB, Liu Y, Willett WC. Height, predictors of C-peptide and cancer risk in men. Int J Epidemiol 2004;33:217-25.
38. Melles E, Jornvall H, Tryggvason S, Danielsson KG, Ekberg K, Tryggvason K, et al. Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity. Cell Mol Life Sci 2004;61:2979-82.
39. Grubb AO. Cystatin C - properties and use as diagnostic marker. Adv Clin Chem 2000;35:63-99.
40. Kos J, Werle B, Lah T, Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 2000;15:84-9.
41. Nealon DA, Henderson AR. Stability of commonly used thiols and of human creatine kinase isoenzymes during storage at various temperature in various media. Clin Chem 1977;23:816-29.
42. Lev EI, Hendler I, Siebner R, Tashma Z, Wiener M, TurKaspa I. Creatine kinase activity decrease with short-term freezing. Enzyme Protein 1994;48:238-42.
43. Szasz G, Gerhardt W, Gruber W. Creatine kinase in serum: 5. Effect of thiols on isoenzyme activity during storage at various temperatures. Clin Chem 1978;24: 1557-63.
44. Jackson AP, Thompson RJ. The stability of creatine kinase isoenzymes studied with two-site monoclonal antibody assays. Ann Clin Biochem 1985;22:310-5.
45. Williams KM, Williams AE, Kline LM, Dodd RY. Stability of serum alanine aminotransferase activity. Transfusion 1987;27:431-3.
46. Niblock AE, Leung FY, Henderson AR. Serum aspartate aminotransferase storage and the effect of pyridoxal phosphate. J Lab Clin Med 1986;108:461-5.
47. Cuccherini B, Nussbaum SJ, Seeff LB, Lukacs L, Zimmerman HJ. Stability of aspartate aminotransferase and alanine aminotransferase activities. J Lab Clin Med 1983; 102:370-6.
48. Donnelly JG, Soldin SJ, Nealon DA, Hicks JM. Stability of twenty-five analytes in human serum at 22°C, 4°C, and -20°C. Pediatr Pathol Lab Med 1995;15:869-74.
49. DiMagno EP, Corle D, O'Brien JF, Masnyk IJ, Go VL, Aamodt R. Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 1989;64:1226-34.
50. Jung K, Bader K, Grutzmann KD. Long-term stability of enzymes in human serum stored in liquid nitrogen. Enzyme 1984;31:209-16.
51. Goldenberg O, Erez E, Nimrod G, Ben Tal N. The ConSurf-DB: pre-calculated evolutionary conservation profiles of protein structures. Nucleic Acids Res 2008.